Physician profile
Benjamin W Murcek
NPI 1124057658
$3,431.26
in general payments reported to CMS, 2019-2025
25 companies · $1,051 in 2025
The $1,051 reported for 2025 was more than what 80% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $219 · 2020: $212 · 2021: $134 · 2022: $415 · 2023: $604 · 2024: $796 · 2025: $1,051.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,395 · Education: $56.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,395.06 |
| Education | $56.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,164.16 | 2022-2025 | Inspire |
| Regeneron Healthcare Solutions, INC. | $557.30 | 2021-2025 | Dupixent, Libtayo |
| Genzyme Corporation | $296.30 | 2021-2025 | |
| Glaxosmithkline, LLC. | $287.52 | 2022-2025 | Nucala |
| Intersect Ent, INC. | $213.73 | 2019-2022 | |
| Stryker Corporation | $109.24 | 2019-2022 | |
| Integra Lifesciences Corporation | $101.22 | 2020-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Acclarent, INC | $94.87 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $74.06 | 2023-2025 | Airsupra, Breztri |
| Optinose US, INC. | $60.51 | 2023-2024 | |
| Checkpoint Surgical, INC | $55.65 | 2023 | Checkpoint Stimulators |
| Mallinckrodt Hospital Products INC. | $50.39 | 2022-2025 | Acthar |
| Phathom Pharmaceuticals, INC. | $46.46 | 2025 | Voquezna |
| Merck Sharp & Dohme LLC | $43.98 | 2019-2025 | Keytruda |
| Mylan Specialty L.P. | $40.61 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $38.79 | 2025 | Coolseal Generator |
| Exelixis INC. | $31.80 | 2023 | Cabometyx |
| Novartis Pharmaceuticals Corporation | $28.22 | 2021 | |
| Ani Pharmaceuticals, INC. | $23.89 | 2025 | Purified Cortrophin Gel |
| Takeda Pharmaceuticals U.S.A., INC. | $21.89 | 2023 | Glassia |
| Access Pro Medical, LLC | $20.59 | 2025 | Matriderm |
| Aerin Medical INC. | $20.30 | 2020 | |
| Shire North American Group INC | $19.50 | 2019 | |
| Medtronic, INC. | $15.88 | 2021 | |
| Cochlear Americas | $14.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Murcek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.